Braster S.A. Net Assets
Braster S.A. net assets. Based on the latest financial reports, Braster S.A. (BRA) has net assets worth zł-5.04 Million PLN (≈ $-1.39 Million USD) as of March 2024. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (zł18.64 Million ≈ $5.13 Million USD) and total liabilities (zł23.68 Million ≈ $6.52 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore net asset growth rate of Braster S.A. to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | zł-5.04 Million |
| % of Total Assets | -27.07% |
| Annual Growth Rate | N/A |
| 5-Year Change | -121.31% |
| 10-Year Change | -150.26% |
| Growth Volatility | 3743.41 |
Net Assets of Braster S.A. (2011–2023)
Net assets of Braster S.A. from 2011 to 2023. This chart illustrates how Braster S.A.'s net assets have evolved over time, based on quarterly financial data. See Braster S.A. (BRA) balance sheet quality index to measure how much of total assets are equity-financed.
Annual Net Assets for Braster S.A. (2011–2023)
The table below shows the annual net assets of Braster S.A. from 2011 to 2023. For live market cap and overall valuation, see BRA company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | zł-4.43 Million ≈ $-1.22 Million |
-781.38% |
| 2022-12-31 | zł650.00K ≈ $178.89K |
-63.17% |
| 2021-12-31 | zł1.76 Million ≈ $485.75K |
-77.67% |
| 2020-12-31 | zł7.90 Million ≈ $2.18 Million |
-61.98% |
| 2019-12-31 | zł20.79 Million ≈ $5.72 Million |
-28.36% |
| 2018-12-31 | zł29.02 Million ≈ $7.99 Million |
-40.54% |
| 2017-12-31 | zł48.80 Million ≈ $13.43 Million |
+40.06% |
| 2016-12-31 | zł34.84 Million ≈ $9.59 Million |
-17.05% |
| 2015-12-31 | zł42.00 Million ≈ $11.56 Million |
+376.61% |
| 2014-12-31 | zł8.81 Million ≈ $2.43 Million |
+48.83% |
| 2013-12-31 | zł5.92 Million ≈ $1.63 Million |
-31.47% |
| 2012-12-31 | zł8.64 Million ≈ $2.38 Million |
+13456.63% |
| 2011-12-31 | zł63.73K ≈ $17.54K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Braster S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 12083822800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Braster S.A. Net Assets Breakdown (December 2023)
Braster S.A. net assets breakdown by equity component as of December 2023.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | zł2.94 Million | % |
| Other Components | zł114.74 Million | % |
| Total Equity | zł-4.43 Million | 100.00% |
Braster S.A. Competitors by Market Cap
The table below lists competitors of Braster S.A. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
TaoWeave Inc.
NASDAQ:TWAV
|
$4.69 Million |
|
Erika Carmel Ltd
TA:BCUR
|
$4.69 Million |
|
Ravi Kumar Distilleries Limited
NSE:RKDL
|
$4.70 Million |
|
Genesis Resources Ltd
AU:GES
|
$4.70 Million |
|
MAST ENERGY DEV. LS -001
F:97D
|
$4.69 Million |
|
Citatah Tbk
JK:CTTH
|
$4.69 Million |
|
Asia Pacific Fibers Tbk
JK:POLY
|
$4.68 Million |
|
Senti Biosciences Inc
NASDAQ:SNTI
|
$4.68 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Braster S.A.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 650,000 to -4,429,000, a change of -5,079,000 (-781.4%).
- Net loss of 4,748,000 reduced equity.
- Other comprehensive income decreased equity by 2,516,000.
- Other factors increased equity by 2,185,000.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | zł-4.75 Million | -107.2% |
| Other Comprehensive Income | zł-2.52 Million | -56.81% |
| Other Changes | zł2.19 Million | +49.33% |
| Total Change | zł- | -781.38% |
Book Value vs Market Value Analysis
This analysis compares Braster S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-12-31 | zł0.03 | zł0.58 | x |
| 2012-12-31 | zł3.49 | zł0.58 | x |
| 2013-12-31 | zł2.37 | zł0.58 | x |
| 2014-12-31 | zł2.10 | zł0.58 | x |
| 2015-12-31 | zł7.48 | zł0.58 | x |
| 2016-12-31 | zł5.65 | zł0.58 | x |
| 2017-12-31 | zł5.32 | zł0.58 | x |
| 2018-12-31 | zł3.16 | zł0.58 | x |
| 2019-12-31 | zł1.09 | zł0.58 | x |
| 2020-12-31 | zł0.32 | zł0.58 | x |
| 2021-12-31 | zł0.07 | zł0.58 | x |
| 2022-12-31 | zł0.02 | zł0.58 | x |
| 2023-12-31 | zł-0.15 | zł0.58 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Braster S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1488.40%
- • Asset Turnover: 0.02x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-165.49%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | -479.08% | 0.00% | 0.00x | 11.93x | zł-311.68K |
| 2012 | -18.71% | 0.00% | 0.00x | 1.04x | zł-2.48 Million |
| 2013 | -50.98% | 0.00% | 0.00x | 1.07x | zł-3.61 Million |
| 2014 | -38.62% | 0.00% | 0.00x | 1.55x | zł-4.28 Million |
| 2015 | -9.56% | 0.00% | 0.00x | 1.13x | zł-8.21 Million |
| 2016 | -41.30% | -3369.56% | 0.01x | 1.86x | zł-17.87 Million |
| 2017 | -51.01% | -6270.03% | 0.01x | 1.51x | zł-29.77 Million |
| 2018 | -68.18% | -2284.30% | 0.02x | 1.88x | zł-22.68 Million |
| 2019 | -74.74% | -2665.01% | 0.01x | 2.35x | zł-17.62 Million |
| 2020 | -202.32% | -8371.20% | 0.01x | 4.54x | zł-16.78 Million |
| 2021 | -515.86% | -2088.30% | 0.02x | 13.45x | zł-9.28 Million |
| 2022 | -601.08% | -174.42% | 0.09x | 37.39x | zł-3.97 Million |
| 2023 | 0.00% | -1488.40% | 0.02x | 0.00x | zł-4.31 Million |
Industry Comparison
This section compares Braster S.A.'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $51,194,642
- Average return on equity (ROE) among peers: -22.80%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Braster S.A. (BRA) | zł-5.04 Million | -479.08% | N/A | $4.69 Million |
| Adiuvo Investment SA (ADV) | $51.55 Million | -101.96% | 0.30x | $2.02 Million |
| Genomtec S.A. (GMT) | $8.30 Million | -108.56% | 0.92x | $10.55 Million |
| Medinice S.A (ICE) | $3.26 Million | -15.53% | 0.50x | $144.91 Million |
| Medicalg (MDG) | $2.83 Million | 67.51% | 0.30x | $59.17 Million |
| Synektik S.A. (SNT) | $190.02 Million | 44.54% | 0.97x | $756.78 Million |
About Braster S.A.
Braster S.A. provides in-home breast cancer examination device worldwide. The company offers Braster System, a device that allows every woman to perform breast examination independently at home; and Braster Pro, a certified medical device that supports the process of breast examination in clinical conditions. It also provides automatic interpretation of results of thermographic breast examination… Read more